Remove tag e-therapeutics
article thumbnail

PharmaShots Weekly Snapshots (May 29 - June 02, 2023)

PharmaShots

Impact Therapeutics Entered into a License and Collaboration Agreement with Eikon Therapeutics to Develop and Commercialize IMP1734 Date: June 02, 2023 | Tags: Impact Therapeutics, Eikon Therapeutics, IMP1734, Pharma, China, Hong Kong, Macau, Taiwan BMS’ Mavacamten Receives the NICE Recommendation for the Treatment of Obstructive Hypertrophic (..)

FDA 40
article thumbnail

Leading innovators in peptide nano-particle conjugates for the pharmaceutical industry

Pharmaceutical Technology

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Putting complex medicines under the microscope

European Pharmaceutical Review

Complex medicines offer diverse therapeutic modalities, including RNA therapeutics and antibody-drug conjugates (ADCs). BT-474 cell line was gene-edited to incorporate a green fluorescent protein (GFP) tag into late endosomes/lysosomes (green). Tewabe A, Abate A, Tamrie M, Seyfu A, Abdela Siraj E. M, Lázaro-Ibáñez, E.,

article thumbnail

Donepezil alternatives: What can I take instead of donepezil?

The Checkup by Singlecare

Besides cholinesterase enzyme inhibitors, Namenda, an NMDA antagonist, is also available as a therapeutic for Alzheimer’s disease. Aduhelm carries a hefty price tag, and it is not appropriate for any other form of dementia, such as dementia with Lewy bodies and vascular dementia. Natural alternatives to donepezil.

Dosage 52
article thumbnail

A history of Johnson & Johnson

pharmaphorum

Between 1976 and 1989, James E. Under his leadership, the company entered new therapeutic areas. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. Acquisitions post-Janssen. Burke was chairman and CEO of J&J. billion the following February.

Vaccines 124